162 related articles for article (PubMed ID: 3532747)
21. Clonidine through the skin in the treatment of essential hypertension: is it practical?
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
[TBL] [Abstract][Full Text] [Related]
22. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
Lueg MC; Herron J; Zellner S
Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
[TBL] [Abstract][Full Text] [Related]
24. Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension.
Houston MC; Hays L
Am Heart J; 1993 Oct; 126(4):918-23. PubMed ID: 8213450
[TBL] [Abstract][Full Text] [Related]
25. Rebound hypertension during initiation of transdermal clonidine.
Stewart M; Burris JF
Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742
[TBL] [Abstract][Full Text] [Related]
26. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
[TBL] [Abstract][Full Text] [Related]
27. Transdermal clonidine application: long-term results in essential hypertension.
Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
[TBL] [Abstract][Full Text] [Related]
28. The USA experience with the clonidine transdermal therapeutic system.
Burris JF
Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
[TBL] [Abstract][Full Text] [Related]
29. Transdermal clonidine for hypertensive patients.
Popli S; Stroka G; Ing TS; Daugirdas JT; Norusis MJ; Hano JE; Gandhi VC
Clin Ther; 1983; 5(6):624-8. PubMed ID: 6627288
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
[TBL] [Abstract][Full Text] [Related]
31. Use of transdermal clonidine in chronic hemodialysis patients.
Rosansky SJ; Johnson KL; McConnell J
Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
[TBL] [Abstract][Full Text] [Related]
32. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
McMahon FG; Jain AK; Vargas R; Fillingim J
Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
[TBL] [Abstract][Full Text] [Related]
33. Randomized, double-blind comparison of transdermal clonidine with oral propranolol.
Franklin SS; Tonkon MJ; Kirschenbaum MA; Dobak JD
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S244-7. PubMed ID: 2455188
[TBL] [Abstract][Full Text] [Related]
34. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Frishman WH; Sherman D; Feinfeld DA
Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
[TBL] [Abstract][Full Text] [Related]
35. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose.
Klein C; Morton N; Kelley S; Metz S
J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715
[TBL] [Abstract][Full Text] [Related]
36. Rebound hypertension after discontinuation of transdermal clonidine.
Schmidt GR; Schuna AA
Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
[No Abstract] [Full Text] [Related]
37. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension.
Burris JF; Papademetriou V; Wallin JD; Cook ME; Weidler DJ
Am J Med; 1991 Jul; 91(1A):22S-28S. PubMed ID: 1867225
[TBL] [Abstract][Full Text] [Related]
38. The use of transdermal clonidine in the hypertensive patient with chronic renal failure.
Lowenthal DT; Saris SD; Paran E; Cristal N
Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hypertension by a new transdermal form of clonidine.
Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
